IDH1 and central nervous system cancer: This finding is confirmed in the literature (Ichimura et al. [62]), where the combination of IDH1 and TP53 mutations is found to be a frequent and early change in the majority of secondary glioblastomas, a more severe type of brain tumor originating from lower grade glioma.